Related Experiment Video

Updated: Jun 5, 2026

Adaptation of Microelectrode Array Technology for the Study of Anesthesia-induced Neurotoxicity in the Intact Piglet Brain
08:23

Adaptation of Microelectrode Array Technology for the Study of Anesthesia-induced Neurotoxicity in the Intact Piglet Brain

Published on: May 12, 2018

Newly postulated neurodevelopmental risks of pediatric anesthesia

Stephen R Hays1, Jayant K Deshpande

  • 1Departments of Anesthesiology & Pediatrics, Vanderbilt University School of Medicine, Nashville, TN, USA. stephen.hays@vanderbilt.edu

Current Neurology and Neuroscience Reports
|January 12, 2011
PubMed

Insights

Concerns exist regarding anesthetic agents and pediatric neurodevelopment. While animal studies show neuronal damage, human relevance and causality remain unclear, with ongoing research to clarify risks.

Area of Science:

  • Neuroscience
  • Developmental Pediatrics
  • Anesthesiology

Background:

  • Animal studies suggest anesthetic agents may cause neuronal damage and neurodevelopmental issues in young subjects.
  • Neonatal pain and stress can also lead to neuronal death and maladaptive behaviors, which anesthetics may prevent.
  • Human studies hint at a link between early childhood anesthesia exposure and learning disabilities, but causality is unproven.

Purpose of the Study:

  • To review current understanding of anesthetic agent exposure and neurodevelopmental outcomes in children.
  • To discuss the implications of animal research and retrospective human data.
  • To highlight the need for ongoing prospective studies to clarify potential risks.

Main Methods:

  • Review of animal studies on anesthetic exposure during critical neurodevelopmental periods.
  • Analysis of retrospective observational human studies on anesthesia and learning disabilities.
  • Consideration of ongoing prospective investigations.

Main Results:

  • Animal models show anesthetic exposure can cause neuronal apoptosis and behavioral changes without pain.
  • Human studies suggest a dose-dependent association between multiple anesthetic exposures and learning disabilities.
  • The direct causality and clinical significance in humans remain undetermined.

Conclusions:

  • The neurodevelopmental risks of pediatric anesthesia require further investigation.
  • Current evidence is insufficient to alter clinical practice.
  • Prospective studies are crucial for determining the safety of anesthetic agents in pediatric populations.

More Related Videos

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity (AIDN): A Translational Neuroscience Approach06:38

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity (AIDN): A Translational Neuroscience Approach

Published on: June 11, 2017

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Local Anesthetics: Adverse Effects01:12

Local Anesthetics: Adverse Effects

While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
Local Anesthetics: Clinical Application as Epidural Anesthesia01:29

Local Anesthetics: Clinical Application as Epidural Anesthesia

Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
General Anesthesia: Overview01:24

General Anesthesia: Overview

Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...